Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.

采用胸腺细胞蛋白（ATG）或细胞蛋白（ALG）法是不适宜于骨髓移植患儿的主要治方法。